XML 32 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Net Loss per Share (Tables)
 9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics and Subsidiaries for the three and nine months ended September 30, 2016, and 2015 (in thousands except share and per share amounts): 
 
 
 
Three months ended September 30, 2016
 
Nine months ended September 30, 2016
 
 
 
Net loss
(Numerator)
 
Shares
(Denominator)
 
Per Share
Amount
 
Net Loss
(Numerator)
 
Shares
(Denominator)
 
Per Share
Amount
 
Net loss - Basic
 
$
(8,353)
 
 
91,441,687
 
$
(0.09)
 
$
(24,880)
 
 
91,095,990
 
$
(0.27)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in fair value of warrant liability
 
$
-
 
 
-
 
$
-
 
$
-
 
 
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive shares related to warrants
 
$
-
 
 
-
 
$
-
 
$
-
 
 
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss - Dilutive
 
$
(8,353)
 
 
91,441,687
 
$
(0.09)
 
$
(24,880)
 
 
91,095,990
 
$
(0.27)
 
 
 
 
 
Three months ended September 30, 2015
 
Nine months ended September 30, 2015
 
 
 
Net loss
(Numerator)
 
Shares
(Denominator)
 
Per Share
Amount
 
Net Loss
(Numerator)
 
Shares
(Denominator)
 
Per Share
Amount
 
Net loss - Basic
 
$
(6,774)
 
 
85,974,751
 
$
(0.08)
 
$
(32,755)
 
 
77,300,375
 
$
(0.42)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in fair value of warrant liability
 
$
(4,141)
 
 
-
 
$
-
 
$
-
 
 
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilutive shares related to warrants
 
$
-
 
 
1,610,352
 
$
-
 
$
-
 
 
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss - Dilutive
 
$
(10,915)
 
 
(87,585,103)
 
$
(0.12)
 
$
(32,755)
 
 
77,300,375
 
$
(0.42)